This security is no longer actively traded. Historical data is preserved for reference.No holders in 2025-Q4, no recent price data
GENE·37185R406·US·adr·Unknown - Unknown
GENE (GENETIC TECH LTD-SP ADR) is held by 2 institutional investors as of Q4 2025. Largest holders: RHUMBLINE ADVISERS ($2,026).
No institutional consensus yet
Fewer than 2 tracked funds currently hold GENE (GENETIC TECH LTD-SP ADR). We surface convergence signals once 2+ institutional funds, insiders, or activists take a position.
This is the correct empty state for thinly-held stocks, not a data issue. New 13F filings arrive quarterly; insider and activist filings update daily.
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Unchanged | 2,650 | $2,026 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $0 | 0.0% | — | 0 |
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer
